Our evidence on apoptosis activation may suggest a role for HPSE inhibitor, making its use particularly advantageous for therapeutic applications, where the progression of tumor growth can be controlled by acting in a balance between apoptosis and autophagy and regulating the autophagic process, without a cytotoxic mechanism affecting cell viability. The gene discussed is HPSE; the disease is neoplasm.